Pulmonary arterial hypertension (PAH) is a syndrome that results from restricted blood ‰ow through the pulmonary arterial circulation, which leads to a pathological increase in pulmonary vascular resistance (PVR) and ultimately to right heart failure. The prognosis of patients with PAH has improved with the recent development of new medications. The need for new noninvasive diagnostic tools is increasing. Magnetic resonance (MR) imaging is the gold standard for assessing the right ventricle (RV). Its high degree of reproducibility makes it ideal for monitoring changes in RV parameters in response to therapy. MR imaging can also provide both anatomical and functional information about pulmonary hemodynamics. This article reviews the current status of MR imaging of the right side of the heart and pulmonary circulation in patients with PAH and other associated pulmonary diseases.
Introduction
Pulmonary arterial hypertension (PAH) is a progressive disease characterized by a pathological increase in resistance of the pulmonary circulation (PVR) that leads to right ventricular dysfunction, exertional impairment, and premature death. 1 There is currently no cure, but several treatments that have become available in recent years have improved the prognosis of patients with this devastating disease. 1, 2 Three classes of drugs developed and approved for the treatment of PAH-prostanoids, endothelin-1 receptor antagonists (ERAs), and phosphodiesterase type 5 (PDE5) inhibitors-have been shown to improve various hemodynamic parameters as well as functional capacity and exercise tolerance. 2 Thus, quantitative assessment of the pulmonary circulation is indispensable to the management of patients with PAH.
This article reviews magnetic resonance (MR) imaging-based techniques to assess the pulmonary circulation. MR imaging has evolved in the last decade as one of the most attractive modalities for this imaging. Traditionally, the diagnostic imaging evaluation of PAH has consisted primarily of echocardiography, invasive right heart catheterization, and ventilation/perfusion scintigraphy. MR imaging has a good balance of high spatial, temporal, and contrast resolution, requires no radiation exposure, is highly accurate and reproducible, and provides both anatomic and functional information. Discussion of analysis of right ventricular (RV) function precedes discussion of the MR imaging-based method for assessing pulmonary circulation, which emphasizes PAH.
Evaluation of the Right Ventricle
PAH, a mean pulmonary arterial pressure (mPAP) of 25 mmHg at rest or 30 mmHg with exercise, is deˆned at cardiac catheterization. 1 Its severity does not strongly correlate with symptoms or survival, but RV mass and size and right atrial (RA) pressure, which re‰ect functional status, are strong predictors of survival in patients with PAH. 3, 4 Thus, evaluation of RV morphology and function is especially important in the management of patients with PAH.
MR imaging is the gold standard for quantifying RV volume and ejection fraction, 4 and fast steadystate free precession (SSFP) sequence with breath holding has become widely available for cardiac imaging in the last decade. In this sequence, contrast depends on the T 2 -to-T 1 ratio of tissues and is largely independent of blood ‰ow, which allows clear demonstration of the endocardial border and precise measurement of RV volume. Simpson's method is most commonly applied to a stack of contiguous short-axis cine loops acquired from base to apex. This approach is highly accurate and does not rely on geometrical assumptions, 5 and its good reproducibility highlights the role of MR imaging in the serial follow-up of patients for such purpose as evaluating the eŠect of therapy. PAH aŠects the right heart and results in RV hypertrophy and dilation and RA enlargement. The extent of RV dilatation, hypertrophy, and systolic dysfunction are directly proportional to the severity of PAH. As an example, a ratio of RV to left ventricular (LV) mass that exceeds 0.6 detects PAH with a sensitivity of 84z and speciˆcity of 71z, and is reported more speciˆc than Doppler echocardiography. 6 Importantly, quantiˆcation of RV functional parameters appears to add prognostic information; in a study of patients with idiopathic PAH, end-diastolic volume indexAE84 mL/m 2 for the RV and Ã40 mL/m 2 for the LV were independent predictors of one-year mortality. 7 More sophisticated analyses of RV performance can be obtained with simultaneous quantiˆcation of pressures with MR imaging-compatible catheters to derive RV volume/pressure loops. 8 In severe PAH, the RV assumes a spherical shape with greater cross-sectional area than the LV, which results in abnormal septal function that impairs LV performance. 9 The interventricular septum (IVS) is ‰at when RV and LV pressures are equal, but paradoxical IVS bowing occurs when RV pressure increases (Fig. 1) . A linear relationship between trans-septal pressure and curvature of the septum is expected based on Laplace's law. Several methods have been proposed to assess this septal curvature. Dellegrottaglie and associates 10 reported the accuracy and reproducibility of the curvature ratio of the LV septum to the free wall in predicting RV systolic pressure in patients clinically known to have or suspected of having PAH, with same-day right heart catheterization as the reference standard. Roeleveld and colleagues 11 reported that systolic pulmonary artery pressure (PAP) was proportional to septal curvature, with a regression coe‹cient (r) of 0.77 (Pº0.001), and demonstrated reduced leftward ventricular septal bowing after treatment with a vasodilator (epoprostenol).
MR imaging can also identify damage to the RV myocardium. In patients with severe pulmonary hypertension, Blyth's group 12 showed delayed gadolinium (Gd) enhancement concentrated at the RV insertion points and in the IVS, the extent of which correlated with RV function and pulmonary hemodynamics. 13, 14 The diagnostic capability and clinical utility of delayed enhancement of the RV insertion points is still unclear.
Evaluation of Pulmonary Circulation using Phase-contrast Cine Imaging
Phase-contrast (or velocity-encoded) cine MR imaging ( Fig. 2) , another important tool, allows direct correlation of phase shift with the velocity of ‰owing spins in the blood vessels and calculation of the velocity from the phase shift. 15 Flow volume can also be obtained by measuring the area of the vessels. This principle has been known since the 1960s, and a breath-hold version of 2-dimensional (2D) phase contrast imaging has been developed and widely used clinically during the past decade. Recently, 3-dimensional (3D) acquisition of phasecontrast images (referred to as 4D-PC MRI) has been proposed, which is expected to allow comprehensive assessment of cardiovascular function.
Two-dimensional phase contrast ‰ow measurement is widely used for noninvasive assessment of blood ‰ow in the heart and great vessels in the assessment of PAH. 15, 16 Stroke volume (SV), a useful measure for PAH, can be calculated with pulmonary arterial ‰ow. Long-term follow-up suggests that a 10-mL change in SV is clinically important in patients with PAH. 7 Phase-contrast cine MR imaging can provide time-velocity curves of the pulmonary artery, which include valuable information about pulmonary hemodynamics. The time-velocity curve of the main pulmonary trunk, which changes smoothly with the cardiac cycle in normal subjects (Fig. 3) , is steep in patients with PAH (Fig. 4) . 17 Several parameters, including acceleration time, acceleration volume, ratio, and average velocity, have been proposed for quantitative analysis of the time-velocity curve. 16 Sanz and colleagues 16 assessed the diagnostic value of these parameters in PAH in 59 subjects and found that average velocity correlated best with mPAP. PAH was correctly diagnosed with average velocity above the cutoŠ value of 11.7 cm/s (measured in expiration), with sensitivity of 92.9z (39/42) and speciˆcity of 82.4z (14/17) . On the other hand, diagnostic ensitivity for the minimum area of pulmonary artery (cutoŠ value, 6.6 cm 2 ) was 92.9z (39/42), and speciˆcity was 88.2z (15/17) . We measured the average velocity in 25 patients with PAH or suspected PAH and found that the average velocity correlated signiˆcantly with mPAP. Compared with right ventricular systolic pressure (RVSP) measured on ultrasonography, the r value was smaller (Fig. 5) . The average velocity determined by MR imaging (cutoŠ value, 7 cm/s, measured in inspiration) was better than that by ultrasonography, with sensitivity of 90.9z and speciˆcity of 92.9z. Sensitivity was 100z and speciˆcity was 57.1z for RVSP measured on ultrasonography (cutoŠ valueÀ35 mmHg).
Nogami and associates 18 used cine-encoding im- (Fig. 3 ).
T. Iwasawa
Magnetic Resonance in Medical Sciences ages to evaluate the regurgitant jet of the tricuspid valve and calculated pulmonary arterial systolic pressure using Bernoulli's equation in a manner similar to that used in ultrasonography. They reported better correlation for systolic pulmonary arterial pressure between phase-contrast MR imaging and catheterization (r＝0.94) than between cardiac ultrasonography and catheterization (r＝0.86). In addition, phase-contrast cine MR imaging can be used to evaluate dynamic changes in arterial cross-section and, therefore, pulmonary artery stiŠness. A change in pulmonary artery (PA) crosssectional area of less than 16z during the cardiac cycle was identiˆed recently as a predictor of mortality in PAH. 19 In addition, alterations in PA elasticity can be detected before development of overt PAH and may aid early detection of abnormal circulatory physiology. 20 Phase-contrast cine MR imaging can be applied to evaluate the right and left pulmonary arteries and allow measurement of stroke volume into each lung. Saouti and coworkers 21 measured ‰ow, resistance, and compliance of each lung using MR imaging and right heart catheterization in patients with chronic thromboembolic pulmonary hypertension. They found low ‰ow and high resistance in the more aŠected lung.
Phase-contrast imaging can be obtained with either breath-holding or respiratory gating. Breathhold image acquisition allows easy alignment of the perpendicular plane to the vessels, but respiratory gating oŠers better temporal resolution. In addition, blood ‰ow measured with breath-hold MR imaging may diŠer from physiological blood ‰ow during normal breathing because breath-holding can change intrathoracic pressure and thereby considerably in‰uence systemic venous return to the heart. 22 Sanz's group 16 obtained phase-contrast images during end-expiratory breath holds preceded by brief hyperventilation. 
Gadolinium (Gd)-enhanced Pulmonary Perfusion Imaging
Ideal perfusion imaging would delineate blood ‰ow at a capillary level. MR imaging of the lung, however, is extremely challenging for several reasons. Intrinsic low proton density and the multiple air-tissue interfaces causes very short T 2 * of the lung parenchyma. Respiratory and cardiac motion and pulmonary blood ‰ow also reduce signal. Thus, short echo time (TE), short repetition time (TR) and another fast imaging technique, such as parallel imaging, are necessary to obtain signal from the lung parenchyma. Hatabu and coworkers 23 were theˆrst to describe 2D dynamic contrast-enhanced perfusion imaging of the lung using ultrashort TE imaging. Furthermore, Ohno and associates 24 proposed Gd-enhanced time-resolved MR angiography to assess pulmonary perfusion whereby T 1 -weighted 3D images of the whole lung are obtained with short TR and TE following rapid injection (4 to 5 mL in one second) of a small amount of contrast material (Fig. 6 ). This method allows simultaneous assessments; quantitative assessment of regional abnormalities in pulmonary perfusion in the entire lung and assessment of disease severity according to PVR and mPAP using a 1.5T MR unit. 25 Time-resolved MR angiography can clearly demonstrate perfusion defect in pulmonary arterial thromboembolism (PTE) (Fig. 7) , and Ohno's group 26 conˆrmed its utility for diagnosing PTE. By vascular zone, sensitivity of MR angiography was 83z, and speciˆcity, 97z; by patient, sensitivity was 92z and speciˆcity, 94z. Still, the diagnostic capability of perfusion MR imaging is less than that of CT for detecting subtle subsegmental PTE. For example, Kluge and associates 27 reported 92z sensitivity of perfusion MR imaging and speciˆcity of subsegmental PTE limited to 75z. They reported the misdiagnosis of emphysema as PTE using MR perfusion imaging because of the di‹culty diagnosing emphysema by loss of signal on nonenhanced MR imaging. Thus, Gd-enhanced perfusion MR imaging is generally not yet the method of choice for PTE.
On the other hand, Gd-enhanced MR imaging can provide useful information about pulmonary hemodynamics. Using short-axis images of the RV and LV of 43 patients with scleroderma obtained after bolus Gd injection using a 3T MR unit, Skrok and colleagues 28 measured pulmonary transit time (PTT) and other parameters in time intensity curves of the RV and LV and found PTT longer in patients with PAH (median, 8.2 s) than those without (median, 6.5 s). Furthermore, PTT correlated signiˆcantly with mPAP measured by right heart catheterization (r＝0.56, Pº0.002). PTT is a useful measure in assessing PAH but is also prolonged in patients with coronary artery disease, LV hypertrophy, and LV dysfunction.
In particular, analysis of MR angiographic signal intensity curves of the lung could yield parameters of vascular physiologic relevance, including mean transit time (MTT), pulmonary blood ‰ow (PBF), and pulmonary blood volume (PBV). 24 Ohno's group 25 applied this method to patients with PPH and found low PBF and prolonged MTT in these patients. They also described good negative correlation between PBF and PVR (r＝-0.79, r 2 ＝0.62, Pº0.001), and moderately positive correlation between MTT and PVR (r＝0.60, r 2 ＝0.36, P＝0.022).
In acute pulmonary thromboembolism (APTE), PBF is the most reliable parameter for distinguish- ing segments aŠected by and without emboli. 29 Ley and associates 30 also reported that MTT measured by Gd-enhanced MR imaging was longer in patients with PAH than normal subjects. The perfusion MR imaging index, which is the ratio between APTEaŠected and total lung volume measured on MR imaging, is a signiˆcant predictor of survival. 29 
PAH and Pulmonary Fibrosis
PAH is an unfavorable complication in idiopathic or secondary pulmonaryˆbrosis that occurs with high frequency in patients with combined pulmonaryˆbrosis and emphysema (CPFE), which is emphysema in the upper lung zone and pulmonarŷ brosis in the lung base. 31 Sergiacomi's group 32 showed that MTT derived from dynamic MR images of the RV correlated with mPAP on right heart catheterization in patients with CPFE. PAH is also associated with collagen vascular disease. In particular, PAH occurs in 10 to 33z of patients with systemic sclerosis and, along with pulmonarŷ brosis, is the most common cause of death in these patients. Ohno and associates 33 demonstrated good correlations between the mean values of PBF, PBV, and MTT derived from time-resolved MR imaging and systolic PAP on right heart catheterization in patients with pulmonaryˆbrosis of collagen vascular disease.
It is interesting that MR imaging parameters for PAH correlate with extent ofˆbrosis on CT images. 33 Previously, we developed a system to measure disease extent automatically on CT images. 34, 35 We compared such quantitative CT images with a map of MTT derived from the original system and found regional prolongation of MTT, which corresponded withˆbrosis on CT, in patients with idiopathic pulmonaryˆbrosis (Fig. 8) . These results call for the consideration of CT and MR imaging as complementary investigative tools in such conditions. A combined CT and MR imaging approach should provide valuable information about pulmonary hemodynamics.
Conclusion
Several imaging modalities can be combined to evaluate the right heart and pulmonary circulation. In particular, advances in echocardiography, CT, and MR imaging have contributed to a progressive shift to a noninvasive approach in the diagnosis and management of PAH. MR imaging provides information on cardiac function and dynamic information regarding regional lung perfusion without irradiation. MR imaging is destined to become the gold standard for imaging the right heart. Though MR imaging is not widely available at present for the evaluation of PAH, further technological advances in MR imaging promise to improve detection of early disease stages or evaluate the mechanisms of action and e‹cacy of novel therapeutic interventions.
